Common use of Narcotic Treatment Services Clause in Contracts

Narcotic Treatment Services. Within a reasonable distance from a member’s residence, the HMO must provide access to narcotic treatment services (NTS) or medication-assisted treatment (MAT) for opioid dependence vial eligible facilities and/or providers. HMOs must regularly monitor their NTS and MAT provider networks to ensure that members have access to these services. Narcotic treatment services include member assessment, screening for drugs of abuse, screening for certain infectious diseases, prescription and administration of narcotic medication, and substance abuse counseling. The ForwardHealth Online Handbook section for ‘Narcotic Treatment’ outlines policy for services provided by narcotic treatment programs certified under Wis. Adm. Code § DHS 75.15. For members who require narcotic treatment, HMOs must ensure access to providers authorized to prescribe opioid dependency agents. Authorized providers include Wis. Adm. Code § DHS 75.15 facilities or physicians who have obtained a Drug Addiction Treatment Act (DATA) 2000 waiver allowing him or her to prescribe buprenorphine-based agents. The requirement to provide narcotic treatment services does not include coverage of opioid dependency agents themselves, which are covered by ForwardHealth. HMO providers must adhere to all policy and prior authorization requirements for coverage of opioid dependency agents.

Narcotic Treatment Services. Within a reasonable distance from a member’s residence, the HMO must provide access to narcotic treatment services (NTS) or medication-assisted treatment (MAT) for opioid dependence vial eligible facilities and/or providers. HMOs must regularly monitor their NTS and MAT provider networks to ensure that members have access to these services. Narcotic treatment services include member assessment, screening for drugs of abuse, screening for certain infectious diseases, prescription and administration of narcotic medication, and substance abuse counseling. The ForwardHealth Online Handbook section for ‘Narcotic Treatment’ outlines policy for services provided by narcotic treatment programs certified under Wis. Adm. Code § DHS 75.15. For members who require narcotic treatment, HMOs must ensure access to providers authorized to prescribe opioid dependency agents. Authorized providers include Wis. Adm. Code § DHS 75.15 facilities or physicians who have obtained a Drug Addiction Treatment Act (DATA) 2000 waiver allowing him or her them to prescribe buprenorphine-based agents. The requirement to provide narcotic treatment services does not include coverage of opioid dependency agents themselves, which are covered by ForwardHealth. HMO providers must adhere to all policy and prior authorization requirements for coverage of opioid dependency agents.

Narcotic Treatment Services. Within a reasonable distance from a member’s residence, the HMO must provide access to narcotic treatment services (NTS) or medication-assisted treatment (MAT) for opioid dependence vial eligible facilities and/or providers. HMOs must regularly monitor their NTS and MAT provider networks to ensure that members have access to these services. Narcotic treatment services include member assessment, screening for drugs of abuse, screening for certain infectious diseases, prescription and administration of narcotic medication, and substance abuse counseling. The ForwardHealth Online Handbook section for ‘Narcotic Treatment’ outlines policy for services provided by narcotic treatment programs certified under Wis. Adm. Code § DHS 75.1575.59. For members who require narcotic treatment, HMOs must ensure access to providers authorized to prescribe opioid dependency agents. Authorized providers include Wis. Adm. Code § DHS 75.15 75.59 facilities or physicians who have obtained a Drug Addiction Treatment Act (DATA) 2000 waiver allowing him or her them to prescribe buprenorphine-based agents. The requirement to provide narcotic treatment services does not include coverage of opioid dependency agents themselves, which are covered by ForwardHealth. HMO providers must adhere to all policy and prior authorization requirements for coverage of opioid dependency agents.